TY - JOUR
T1 - MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation
AU - Schaefer, Inga Marie
AU - Wang, Yuexiang
AU - Liang, Cher Wei
AU - Bahri, Nacef
AU - Quattrone, Anna
AU - Doyle, Leona
AU - Marinõ-Enríquez, Adrian
AU - Lauria, Alexandra
AU - Zhu, Meijun
AU - Debiec-Rychter, Maria
AU - Grunewald, Susanne
AU - Hechtman, Jaclyn F.
AU - Dufresne, Armelle
AU - Antonescu, Cristina R.
AU - Beadling, Carol
AU - Sicinska, Ewa T.
AU - Van De Rijn, Matt
AU - Demetri, George D.
AU - Ladanyi, Marc
AU - Corless, Christopher L.
AU - Heinrich, Michael C.
AU - Raut, Chandrajit P.
AU - Bauer, Sebastian
AU - Fletcher, Jonathan A.
N1 - Publisher Copyright:
© 2017 The Author(s).
PY - 2017/3/8
Y1 - 2017/3/8
N2 - KIT, PDGFRA, NF1 and SDH mutations are alternate initiating events, fostering hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression to malignancy. The most frequent secondary alteration, demonstrated in ∼70% of GISTs, is chromosome 14q deletion. Here we report hemizygous or homozygous inactivating mutations of the chromosome 14q MAX gene in 16 of 76 GISTs (21%). We find MAX mutations in 17% and 50% of sporadic and NF1-syndromic GISTs, respectively, and we find loss of MAX protein expression in 48% and 90% of sporadic and NF1-syndromic GISTs, respectively, and in three of eight micro-GISTs, which are early GISTs. MAX genomic inactivation is associated with p16 silencing in the absence of p16 coding sequence deletion and MAX induction restores p16 expression and inhibits GIST proliferation. Hence, MAX inactivation is a common event in GIST progression, fostering cell cycle activity in early GISTs.
AB - KIT, PDGFRA, NF1 and SDH mutations are alternate initiating events, fostering hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression to malignancy. The most frequent secondary alteration, demonstrated in ∼70% of GISTs, is chromosome 14q deletion. Here we report hemizygous or homozygous inactivating mutations of the chromosome 14q MAX gene in 16 of 76 GISTs (21%). We find MAX mutations in 17% and 50% of sporadic and NF1-syndromic GISTs, respectively, and we find loss of MAX protein expression in 48% and 90% of sporadic and NF1-syndromic GISTs, respectively, and in three of eight micro-GISTs, which are early GISTs. MAX genomic inactivation is associated with p16 silencing in the absence of p16 coding sequence deletion and MAX induction restores p16 expression and inhibits GIST proliferation. Hence, MAX inactivation is a common event in GIST progression, fostering cell cycle activity in early GISTs.
UR - http://www.scopus.com/inward/record.url?scp=85014744004&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85014744004&partnerID=8YFLogxK
U2 - 10.1038/ncomms14674
DO - 10.1038/ncomms14674
M3 - Article
C2 - 28270683
AN - SCOPUS:85014744004
SN - 2041-1723
VL - 8
JO - Nature communications
JF - Nature communications
M1 - 14674
ER -